Evidence map›Paper›PMID 38107289›Full record

ArticleHeliyon2023

Neuroprotective effect of

Thaneeya Hawiset, Napatr Sriraksa, Utcharaporn Kamsrijai, Siwaporn Praman, Prachak Inkaew

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Neuroprotective effects ofBiomedical reports · 2026
    Article
  2. Article
  3. Article
  4. Advances in pharmacological and pharmaceutical sciences · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thaneeya HawisetSchool of Medicine, Mae Fah Luang University, Muang, Chiang Rai, 57100, Thailand.
Napatr SriraksaSchool of Medical Sciences, University of Phayao, Muang, Phayao, 56000, Thailand.
Utcharaporn KamsrijaiSchool of Medicine, Mae Fah Luang University, Muang, Chiang Rai, 57100, Thailand.
Siwaporn PramanSchool of Medicine, Mae Fah Luang University, Muang, Chiang Rai, 57100, Thailand.
Prachak InkaewSchool of Science, Mae Fah Luang University, Muang, Chiang Rai, 57100, Thailand.
Mae Fah Luang University · THUniversity of Phayao · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is characterized by progressive memory loss caused from alterations in the central cholinergic system. While existing medications often have adverse effects, traditional use of

Indexed as

Alzheimer's diseaseCholinergic systemMemory impairmentNeuronal densityOxidative stressScopolamineTiliacora triandra

Identifiers

PMID38107289
PMCPMC10724565
OpenAlexW4388817536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.